These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

919 related articles for article (PubMed ID: 34229852)

  • 1. Extracellular vesicles in cardiovascular disease.
    Huang C; Neupane YR; Lim XC; Shekhani R; Czarny B; Wacker MG; Pastorin G; Wang JW
    Adv Clin Chem; 2021; 103():47-95. PubMed ID: 34229852
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating Extracellular Vesicles As Biomarkers and Drug Delivery Vehicles in Cardiovascular Diseases.
    de Freitas RCC; Hirata RDC; Hirata MH; Aikawa E
    Biomolecules; 2021 Mar; 11(3):. PubMed ID: 33808038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular Vesicles in Cardiovascular Diseases: Alternative Biomarker Sources, Therapeutic Agents, and Drug Delivery Carriers.
    Chong SY; Lee CK; Huang C; Ou YH; Charles CJ; Richards AM; Neupane YR; Pavon MV; Zharkova O; Pastorin G; Wang JW
    Int J Mol Sci; 2019 Jul; 20(13):. PubMed ID: 31277271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Extracellular Vesicles in Cardiovascular Theranostics.
    Bei Y; Das S; Rodosthenous RS; Holvoet P; Vanhaverbeke M; Monteiro MC; Monteiro VVS; Radosinska J; Bartekova M; Jansen F; Li Q; Rajasingh J; Xiao J
    Theranostics; 2017; 7(17):4168-4182. PubMed ID: 29158817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Emerging prospects of extracellular vesicles for brain disease theranostics.
    Wang R; Wang X; Zhang Y; Zhao H; Cui J; Li J; Di L
    J Control Release; 2022 Jan; 341():844-868. PubMed ID: 34953980
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for loading therapeutics into extracellular vesicles and generating extracellular vesicles mimetic-nanovesicles.
    Nasiri Kenari A; Cheng L; Hill AF
    Methods; 2020 May; 177():103-113. PubMed ID: 31917274
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Strategies for the use of Extracellular Vesicles for the Delivery of Therapeutics.
    Sil S; Dagur RS; Liao K; Peeples ES; Hu G; Periyasamy P; Buch S
    J Neuroimmune Pharmacol; 2020 Sep; 15(3):422-442. PubMed ID: 31456107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EV Cargo Sorting in Therapeutic Development for Cardiovascular Disease.
    Sherman CD; Lodha S; Sahoo S
    Cells; 2021 Jun; 10(6):. PubMed ID: 34203713
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular vesicles in the diagnosis and treatment of cardiovascular disease. What's behind? What do we need to implement them into clinical practice?
    Nowicka G
    Int J Biochem Cell Biol; 2024 Jul; 172():106600. PubMed ID: 38806094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects and challenges of extracellular vesicle-based drug delivery system: considering cell source.
    Meng W; He C; Hao Y; Wang L; Li L; Zhu G
    Drug Deliv; 2020 Dec; 27(1):585-598. PubMed ID: 32264719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolites as extracellular vesicle cargo in health, cancer, pleural effusion, and cardiovascular diseases: An emerging field of study to diagnostic and therapeutic purposes.
    Zhang Y; Liang F; Zhang D; Qi S; Liu Y
    Biomed Pharmacother; 2023 Jan; 157():114046. PubMed ID: 36469967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extracellular vesicles: Roles and applications in drug-induced liver injury.
    Umbaugh DS; Jaeschke H
    Adv Clin Chem; 2021; 102():63-125. PubMed ID: 34044913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracellular vesicles characteristics and emerging roles in atherosclerotic cardiovascular disease.
    Hafiane A; Daskalopoulou SS
    Metabolism; 2018 Aug; 85():213-222. PubMed ID: 29727628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Advances in Extracellular-Vesicles-Based Diagnostic and Therapeutic Approaches for Ocular Diseases.
    Su Y; Chen M; Xu W; Gu P; Fan X
    ACS Nano; 2024 Aug; 18(34):22793-22828. PubMed ID: 39141830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Engineered extracellular vesicles and their mimetics for clinical translation.
    Kim H; Kim D; Nam H; Moon S; Kwon YJ; Lee JB
    Methods; 2020 May; 177():80-94. PubMed ID: 31626895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extracellular vesicles for drug delivery.
    Vader P; Mol EA; Pasterkamp G; Schiffelers RM
    Adv Drug Deliv Rev; 2016 Nov; 106(Pt A):148-156. PubMed ID: 26928656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular vesicles and cardiovascular system: Biomarkers and Cardioprotective Effectors.
    Femminò S; Penna C; Margarita S; Comità S; Brizzi MF; Pagliaro P
    Vascul Pharmacol; 2020 Dec; 135():106790. PubMed ID: 32861822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular vesicles in liver disease and potential as biomarkers and therapeutic targets.
    Szabo G; Momen-Heravi F
    Nat Rev Gastroenterol Hepatol; 2017 Aug; 14(8):455-466. PubMed ID: 28634412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular vesicle-based therapeutics: Extracellular vesicles as therapeutic targets and agents.
    Takahashi Y; Takakura Y
    Pharmacol Ther; 2023 Feb; 242():108352. PubMed ID: 36702209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular vesicle interplay in cardiovascular pathophysiology.
    Saheera S; Jani VP; Witwer KW; Kutty S
    Am J Physiol Heart Circ Physiol; 2021 May; 320(5):H1749-H1761. PubMed ID: 33666501
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.